Connect with us

Company News

AuroMedics Pharma Recalls Over 59000 Vials Of Antipsychotic Injection In US

Aurobindo Pharma arm AuroMedics Pharma LLC is recalling 59.5 thousand vials of antipsychotic Fluphenazine Decanoate injection USP 125mg/5mL, (5 mL multiple dose vial) from the US market, the USFDA said.

AuroMedics Pharma LLC is recalling 59,500 vials of the injection on account of “Discoloration; hazy solution found in one vial instead of a clear solution,” the US heath regulator said in its latest Enforcement Report.

The product was distributed to major wholesalers/distributors who may have further distributed the product throughout the US, it added.

The voluntary ongoing recall is a class II recall, the United States Food and Drug Administration (USFDA) said.

As per the regulator, class II recall is initiated in a “situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote”.

Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (for example chronic schizophrenics).-Business Standard

Copyright © 2024 Medical Buyer

error: Content is protected !!